• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, July 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Arming the body’s immune cells

Bioengineer by Bioengineer
March 10, 2020
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UC scientists have uncovered a mechanism that could lead to new immunotherapies for patients with head and neck cancers

IMAGE

Credit: Colleen Kelley / University of Cincinnati


Researchers at UC have discovered a previously unknown mechanism that could explain the reason behind decreased immune function in cancer patients and could be a new therapeutic target for immunotherapy for those with head and neck cancers.

The authors share these findings in an article published in the journal Frontiers in Pharmacology.

Immunotherapy is a type of cancer treatment that boosts the body’s natural defenses to fight cancer.

Led by Laura Conforti, professor in the Department of Nephrology and Hypertension at the UC College of Medicine, the team discovered that a reduced interaction between a molecule called calmodulin and an ion channel (KCa3.1) in the immune cells of cancer patients plays an important role in the reduced function of these cells. The team performed experiments on white blood cells called cytotoxic T-cells taken from the blood of patients with head and neck cancer.

“Cytotoxic T-cells are like the soldiers of our immune system and are our body’s first line of defense against cancerous tumors,” says first author Ameet Chimote, research scientist in Conforti’s laboratory. “Just like how soldiers on the frontlines penetrate the enemy’s defense and launch a massive attack, these cytotoxic T-cells are expected to penetrate the solid tumors by migrating within the tumor mass and then secreting chemicals called cytokines to kill these tumor cells. Sadly, for some reason, these cells do not function properly in patients with cancer, and they do not penetrate the tumors and attack the tumor cells, causing the cancerous tumors to grow uncontrollably.”

“Identifying the mechanism of this underlying dysfunction can help us identify molecules that we can target with drugs and ultimately restore the ability of these cells to enter and kill the tumors,” says Conforti. She says that molecules, known as ion channels, are present in the T-cell membranes and are essential for T-cell function.

“In this study, we were able to show that the function of these channels in T-cells from cancer patients is decreased which results in a decreased T-cell accumulation in solid tumors,” Conforti says.

These types of channels require a signaling molecule called calmodulin to bind to them in order to function to their full capacity; this is needed even more in cancer T-cells.

Using several intricate microscopy imaging techniques on T-cells isolated from the blood of cancer patients, the team found out that, as compared to T-cells from healthy individuals, the cancer T-cells have fewer calmodulin molecules in their membranes.

“This would mean that there is less calmodulin binding to the channels in the T-cells from cancer patients,” Conforti says. “As previously stated, the channels do not function if the calmodulin does not bind to them. Thus, the decreased calmodulin binding in T-cells from cancer patients results in decreased function and leads to reduced tumor infiltration and killing of the cancer cells.”

“So back to our soldiers: If they were present at a battlefield, but none of them have any weaponry, this will hinder their ability to infiltrate the enemy lines. Now, if we arm each soldier adequately, we would boost their function. They can do their job. Similarly, we observed that if we increase the function of these channels by drugs that enhance their activity, the cancer patients’ T-cells can penetrate the tumors better and also produce increased cytokines which can kill tumor cells,” Chimote says. “These are exciting findings that could lead to additional treatments for patients with cancer.”

“These findings strengthen the therapeutic potentials of [these] activators, which could restore cytotoxic T-cell functionality and can ultimately lead to additional immunotherapeutic options for patients with cancer,” Conforti adds.

###

This work was funded by grant support from the NIH (grant R01CA95286, T32CA117846T) and a Clinical and Translational Science Award (CTSA) — awarded KL2 Mentored grant and a grant from CCTST (1UL1TR001425-01). Researchers cite no conflict of interest.

Media Contact
Katie Pence
katie.pence@uc.edu
513-558-4561

Original Source

https://www.uc.edu/news/articles/2020/03/n20896798.html

Related Journal Article

http://dx.doi.org/10.3389/fphar.2020.00143

Tags: cancerCell BiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

July 29, 2025
blank

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

July 29, 2025

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

July 28, 2025

Virion Movement in Sialoglycan-Cleaving Respiratory Viruses

July 28, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    56 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Merbecovirus S2 Vaccines Trigger Cross-Reactive MERS Protection

Cracking the Code of Cancer Drug Resistance

Peptidoglycan Links Prevent Lysis in Gram-Negative Bacteria

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.